Medical Devices Startups
6,520 companies tagged Medical Devices, with their investors and founders.
ComKardia is developing an AI-powered decision-support platform for coronary artery disease and PCI planning that builds a patient-specific digital twin to help interventional cardiologists plan stent selection, sizing, and placement within the cath lab workflow. The company targets interventional cardiology and plans to distribute its imaging-guided PCI software through a licensing and SaaS model.
0 investors
Companion Spine develops motion-preserving, minimally invasive spinal implant technologies, building on the Paradigm Spine portfolio for use by spine surgeons. The company operates in the medical device industry with commercial reach across Europe, North America, Latin America, and Asia-Pacific.
0 investors
The Concinnity Company provides a cloud-based process management and automation platform designed to reduce delays and improve efficiency in clinical trials. The platform addresses workflow challenges in R&D environments where repeatability, scalability, and compliance are critical.
0 investors
Continuity Biosciences develops adaptive precision drug-delivery platforms that combine engineering and biology to help therapies reach their intended targets more effectively. The company works across multiple therapeutic applications rather than a single drug or disease, bridging medtech and biotech.
0 investors
Conversio Health provides personalized therapeutics, technologies, and services for patients with chronic respiratory conditions and their caregivers. Founded in 2012, the company focuses on chronic respiratory care with the goal of improving outcomes and lowering costs.
0 investors
Coronado Aesthetics sells the Sebacia AcneIQ Massager, a rechargeable device designed for in-office acne treatment that works with existing 1064nm lasers without requiring additional capital equipment. The product targets aesthetic practitioners and dermatologists seeking a drug-free acne treatment option FDA-cleared for mild to moderate acne.
0 investors
CQens designs devices and methods that heat plant-based and medicant-infused formulations to produce aerosols for inhalation, with a focus on harm reduction. The company operates in Nevada and California, holding a portfolio of 111 US and international patents.
0 investors
Creative Medical Technology Holdings (CELZ) is a biotechnology company developing regenerative medicine and immunotherapy platforms for conditions in immunology, endocrinology, urogynecology, and orthopedics. Its technologies include autologous immunotherapy (ImmCelz), an allogenic cell platform (AlloStem), a cellular reprogramming platform (iPSCELZ), and rapid autologous therapy programs (StemSpine, OvaStem, CaverStem).
0 investors
Credence MedSystems develops drug delivery and medical device technologies for pharmaceutical manufacturers and healthcare providers. The company is led by executives with extensive backgrounds in medical technology commercialization and surgical device innovation.
0 investors
Crossover is a stealth-mode medical device company developing two Class II (510(k) pathway) implant systems for ankle fracture fixation, specifically fibular nailing and syndesmosis repair. It targets the US lower-extremity trauma fixation market and is building the devices with an acquisition-oriented strategy for strategic orthopedic partners and surgeon advisors.
0 investors
Croton Healthcare is a healthcare company. The page identifies its board of managers but does not describe the company's specific products or services.
0 investors
CryoLife develops technologies for aortic treatment, positioning itself in the cardiovascular medical device field.
0 investors
Cue Biopharma is a precision immunotherapy company developing engineered therapies targeting allergic and autoimmune diseases. The company's pipeline includes CUE-221 for IgE-mediated allergic disease and CUE-401 advancing from its proprietary Immuno-STAT platform for autoimmune conditions.
0 investors
Curelab Oncology develops anti-cancer drugs with a focus on gene therapy and immuno-oncology, taking programs from early discovery through clinical development. It is a biotech company operating in the oncology drug development space.
0 investors
Cx Precision Medicine develops blood-based diagnostic tests for Alzheimer's and other neurodegenerative diseases, delivering precision medicine tools for early diagnosis and personalized treatment in primary care settings.
0 investors
CYduct Diagnostics (CYductDX) develops and markets medical devices for breast cancer risk assessment, early detection, and diagnosis through an intraductal approach within the mammary ducts. It serves women and their clinicians, applying genetic and proteomic testing to breast health in the medical device and diagnostics industry.
0 investors
Cypris Medical develops minimally-invasive medical devices and treatments designed specifically for plastic surgeons to deliver results comparable to traditional surgery with shorter recovery times. The company combines medical device expertise with input from practicing surgeons to address unmet needs in the plastic surgery market.
0 investors
Cyprium Therapeutics develops therapies for rare genetic diseases, with a focus on treatments for Menkes disease. The company's pipeline includes ZYCUBO (copper histidinate) and AAV-ATP7A gene therapy candidates.
0 investors
Cyrcadia Health develops technology based on circadian rhythm science to detect tissue disruption and cancer risk. The company's core innovation relates circadian clock dysregulation to cancer development and prognosis.
0 investors
CytoDyn is a biopharmaceutical company conducting clinical trials, including a Phase 2 colorectal cancer trial.
0 investors
Cytonics develops biologic therapies targeting osteoarthritis, with lead candidate CYT-108, a recombinant protease inhibitor for knee joint regeneration based on a novel pathway to restore cartilage-secreting cells. The company funds development through equity crowdfunding from individual investors rather than venture capital.
0 investors
Diagnostic Biochips develops multichannel neural probes for extracellular recording in electrophysiology research, along with cloud-based software for spike sorting and analysis. It serves neuroscience researchers studying the brain at the neural network level.
0 investors
Diality is a medical device company developing a home hemodialysis machine and related solutions for patients with kidney disease, aimed at supporting new decentralized kidney-care models. The Series-B company serves the dialysis and nephrology market and is based in Irvine, California.
0 investors
Diceros Therapeutics develops Verasone, a drug candidate combining two existing therapies for treatment of chronic rhinosinusitis via sinonasal irrigation. The company is advancing the treatment through clinical trials to provide improved efficacy and reduced side effects compared to existing options.
0 investors